Search Results - "Pozzi, Ernesto"

Refine Results
  1. 1

    Rescue Use of Beclomethasone and Albuterol in a Single Inhaler for Mild Asthma by Papi, Alberto, Canonica, Giorgio W, Maestrelli, Piero, Paggiaro, Pierluigi, Olivieri, Dario, Pozzi, Ernesto, Crimi, Nunzio, Vignola, Antonio M, Morelli, Paolo, Nicolini, Gabriele, Fabbri, Leonardo M

    Published in The New England journal of medicine (17-05-2007)
    “…Patients with mild persistent asthma are often advised to use inhaled corticosteroids on a regular schedule. In this trial, such patients treated themselves…”
    Get full text
    Journal Article
  2. 2

    Long-term Outcome after Pulmonary Endarterectomy by Corsico, Angelo G, D'Armini, Andrea M, Cerveri, Isa, Klersy, Catherine, Ansaldo, Elena, Niniano, Rosanna, Gatto, Elena, Monterosso, Cristian, Morsolini, Marco, Nicolardi, Salvatore, Tramontin, Corrado, Pozzi, Ernesto, Vigano, Mario

    “…There are few follow-up studies on long-term cardiopulmonary function after pulmonary endarterectomy (PEA), the operation of choice for chronic thromboembolic…”
    Get full text
    Journal Article
  3. 3

    Oncogenes in non-small-cell lung cancer: emerging connections and novel therapeutic dynamics by Stella, Giulia M, Dr, Luisetti, Maurizio, Prof, Pozzi, Ernesto, Prof, Comoglio, Paolo M, Prof

    Published in The lancet respiratory medicine (01-05-2013)
    “…Summary Non-small-cell lung cancer is a heterogeneous disease that is difficult to treat. Through efforts to define the molecular mechanisms involved in lung…”
    Get full text
    Journal Article
  4. 4

    EGFR and KRAS mutational profiling in fresh non-small cell lung cancer (NSCLC) cells by Stella, Giulia M., Scabini, Roberta, Inghilleri, Simona, Cemmi, Francesca, Corso, Simona, Pozzi, Ernesto, Morbini, Patrizia, Valentini, Adele, Dore, Roberto, Ferrari, Simona, Luisetti, Maurizio, Zorzetto, Michele

    “…Purpose Knowledge of tumor mutational status has become a priority for effective NSCLC-tailored treatment. NSCLC diagnosis is more often reached through…”
    Get full text
    Journal Article
  5. 5

    Successful whole lung lavage in pulmonary alveolar proteinosis secondary to lysinuric protein intolerance: a case report by Ceruti, Michele, Rodi, Giuseppe, Stella, Giulia M, Adami, Andrea, Bolongaro, Antonia, Baritussio, Aldo, Pozzi, Ernesto, Luisetti, Maurizio

    Published in Orphanet journal of rare diseases (26-03-2007)
    “…Pulmonary alveolar proteinosis (PAP) is a rare disease characterised by accumulation of lipoproteinaceous material within alveoli, occurring in three…”
    Get full text
    Journal Article
  6. 6

    Relationship Between Diffuse Pulmonary Fibrosis, Alveolar Proteinosis, and Granulocyte-Macrophage Colony Stimulating Factor Autoantibodies by LUISETTI, Maurizio, BRUNO, Pierdonato, MARIOTTA, Salvatore, KADIJA, Zamir, SUZUKI, Takuji, RAFFA, Salvatore, ROSARIA TORRISI, Maria, CAMPO, Ilaria, MARIANI, Francesca, POZZI, Ernesto, TRAPNELL, Bruce C

    Published in Respiratory care (01-10-2011)
    “…Extensive pulmonary fibrosis is a rare occurrence in pulmonary alveolar proteinosis. We report 2 cases that have interesting implications. A female patient was…”
    Get full text
    Journal Article
  7. 7

    Factors Influencing Oxidative Imbalance in Pulmonary Fibrosis: An Immunohistochemical Study by Inghilleri, Simona, Morbini, Patrizia, Campo, Ilaria, Zorzetto, Michele, Oggionni, Tiberio, Pozzi, Ernesto, Luisetti, Maurizio

    Published in Pulmonary Medicine (01-01-2011)
    “…Background. Idiopathic Pulmonary Fibrosis (IPF) is a fatal lung disease of unknown etiology characterized by interstitial fibrosis determining irreversible…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Synchronous lung cancers: when same histological types feature different molecular profiles and response phenotypes by Stella, Giulia M, Cemmi, Francesca, Inghilleri, Simona, Zorzetto, Michele, Luisetti, Maurizio, Pozzi, Ernesto

    Published in Journal of Cancer (01-01-2011)
    “…We discuss the case of synchronous bilateral lung cancers which feature the same histological phenotype and a different EGFR mutational profile. Both…”
    Get full text
    Journal Article
  10. 10

    SP-A binds alpha1-antitrypsin in vitro and reduces the association rate constant for neutrophil elastase by Gorrini, Marina, Lupi, Anna, Iadarola, Paolo, Dos Santos, Conceição, Rognoni, Paola, Dalzoppo, Daniele, Carrabino, Natalia, Pozzi, Ernesto, Baritussio, Aldo, Luisetti, Maurizio

    Published in Respiratory research (13-12-2005)
    “…Alpha1-antitrypsin and surfactant protein-A (SP-A) are major lung defense proteins. With the hypothesis that SP-A could bind alpha1-antitrypsin, we designed a…”
    Get full text
    Journal Article
  11. 11

    Caveolin‐1 as a promoter of tumour spreading: when, how, where and why by Senetta, Rebecca, Stella, Giulia, Pozzi, Ernesto, Sturli, Niccolo, Massi, Daniela, Cassoni, Paola

    Published in Journal of cellular and molecular medicine (01-03-2013)
    “…Caveolae are non‐clathrin invaginations of the plasma membrane in most cell types; they are involved in signalling functions and molecule trafficking, thus…”
    Get full text
    Journal Article
  12. 12

    Targeting EGFR in non-small-cell lung cancer: Lessons, experiences, strategies by Stella, Giulia M, Luisetti, Maurizio, Inghilleri, Simona, Cemmi, Francesca, Scabini, Roberta, Zorzetto, Michele, Pozzi, Ernesto

    Published in Respiratory medicine (01-02-2012)
    “…Summary Cancer is a genetic disease and this concept is now widely exploited by both scientists and clinicians to design new targeted molecules. Indeed many…”
    Get full text
    Journal Article
  13. 13
  14. 14

    MET mutations in cancers of unknown primary origin (CUPs) by Stella, Giulia M., Benvenuti, Silvia, Gramaglia, Daniela, Scarpa, Aldo, Tomezzoli, Anna, Cassoni, Paola, Senetta, Rebecca, Venesio, Tiziana, Pozzi, Ernesto, Bardelli, Alberto, Comoglio, Paolo M.

    Published in Human mutation (01-01-2011)
    “…Cancer of unknown primary origin (CUP) defines metastatic disease of unknown origin, accounting for 3–5% of all cancers. Growing evidence demonstrates that…”
    Get full text
    Journal Article
  15. 15

    Foxp3 Expressing CD4 + CD25 + and CD8 +CD28 − T Regulatory Cells in the Peripheral Blood of Patients with Lung Cancer and Pleural Mesothelioma by Meloni, Federica, Morosini, Monica, Solari, Nadia, Passadore, Ileana, Nascimbene, Caterina, Novo, Monique, Ferrari, Marco, Cosentino, Marco, Marino, Franca, Pozzi, Ernesto, Fietta, Anna M.

    Published in Human immunology (2006)
    “…The role of T regulatory (Treg) cells in human cancer has not yet been clarified. We assessed the presence and function of CD4 + and CD8 + Treg cell subsets in…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Non-neuronal cholinergic system in airways and lung cancer susceptibility by Saracino, Laura, Zorzetto, Michele, Inghilleri, Simona, Pozzi, Ernesto, Stella, Giulia Maria

    Published in Translational lung cancer research (01-08-2013)
    “…In the airway tract acetylcholine (ACh) is known to be the mediator of the parasympathetic nervous system. However ACh is also synthesized by a large variety…”
    Get full text
    Journal Article
  19. 19

    Assessment of emphysema in COPD: a functional and radiologic study by Cerveri, Isa, Dore, Roberto, Corsico, Angelo, Zoia, Maria C, Pellegrino, Riccardo, Brusasco, Vito, Pozzi, Ernesto

    Published in Chest (01-05-2004)
    “…A combination of functional measurements reflecting a decrease in maximum flow, a degree of lung hyperinflation, the relationship between maximum inspiratory…”
    Get more information
    Journal Article
  20. 20

    Acebrophylline: an airway mucoregulator and anti-inflammatory agent by Pozzi, E

    Published in Monaldi archives for chest disease (01-06-2007)
    “…Acebrophylline is an airway mucus regulator with antiinflammatory action. The drug's approach involves several points of attack in obstructive airway disease…”
    Get full text
    Journal Article